Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
Lei QiaoJing MaZihao ZhangWenhai SuiChungang ZhaiDan XuZunzhe WangHuixia LuMeng ZhangCheng ZhangWenqiang ChenYun ZhangPublished in: Circulation research (2021)
CMA function becomes impaired during the progression of atherosclerosis, which increases NLRP3 inflammasome activation and secretion of IL-1β, promoting vascular inflammation and atherosclerosis progression. Our study unveils a new mechanism by which NLRP3 inflammasome is regulated in macrophages and atherosclerosis, thus providing a new insight into the role of autophagy-lysosomal pathway in atherosclerosis. Pharmacological activation of CMA may provide a novel therapeutic strategy for atherosclerosis and other NLRP3 inflammasome/IL-1β-driven diseases.